Thirty-seven-year durability of a Starr-Edwards aortic prosthesis: Case report and brief review of the literature

Texas Heart Institute Journal

Volumn 32, Issue 1, 2005, Pages 99-101

  Ozkokeli, Mehmet ^a,c   Ates, Mehmet ^b   Ekinci, Abdurrahman ^b   Akcar, Murat ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b Research Hospital   (Turkey)

^c Beskavaklar Mah   (Turkey)

Author keywords

Aortic valve prosthesis; Durable medical equipment; Endocarditis, bacterial; Heart valve prosthesis; Human; Male; Postoperative complications; Reoperation; Time factors

Indexed keywords

CEFAZOLIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ANEMIA; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CARDIOPULMONARY BYPASS; CASE REPORT; ELECTROCARDIOGRAM; FEVER; HEART VALVE PROSTHESIS; HUMAN; LEUKOCYTOSIS; MALE; REVIEW; STAPHYLOCOCCUS AUREUS; STARR EDWARDS VALVE PROSTHESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 14644413485     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Lefrak EA, Starr A. Cardiac valve prostheses, New York: Appleton-Century-Crofts; 1979. p. 67-118.
2. Machler HE, Schmidt CH, Neuner P, Iberer F, Anelli-Monti M, Dacar D, et al. Twenty-four years' implant duration of the aortic Starr-Edwards Silastic ball prosthesis: a valve of the past? Eur J Cardiothorac Surg 1993;7:114-6.
3. Cobanoglu A, Starr A. Starr-Edwards silastic ball prosthesis: state of the art 25 years later. Cardiac Surg State Art Rev 1987;1:171-81.
4. Godje OL, Fischlein T, Adelhard K, Nollert G, Klinner W, Reichart B. Thirty-year results of Starr-Edwards prostheses in the aortic and mitral position. Ann Thorac Surg 1997; 63:613-9.
5. Godje O, Brenner P, Fischlein T, Reichart B. Thirty years survival after double valve replacement with Starr-Edwards prostheses in aortic and mitral position. Eur J Cardiothorac Surg 1997;11:391-3.
6. Lazaros GA, Dounis GB, Panou FC, Georgoulas VP, Zacharoulis AA. Thirty one-year durability of a Starr-Edwards aortic prosthesis. J Cardiovasc Surg (Torino) 1998;39:659-62.
7. Grunkemeier GL, Starr A. Late ball variance with the Model 1000 Starr-Edwards aortic valve prosthesis. Risk analysis and strategy of operative management. J Thorac Cardiovasc Surg 1986;91:918-23.
8. Gohlke-Barwolf C, Acar J, Oakley C, Butchart E, Burckhart D, Bodnar E, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320-30.
9. Pedersen WR, Walker M, Olson JD, Gobel F, Lange HW, Daniel JA, et al. Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis. Chest 1991; 100:351-6.
10. Goshima M, Shiono M, Yamamoto T, Inoue T, Hata M, Sezai A, et al. Reoperation for a Starr-Edwards ball valve prosthesis implanted in mitral position 31 position years ago [in Japanese]. Kyobu Geka 2003;56:535-40.
11. Bessell JR, Gower G, Craddock DR, Stubberfield J, Maddern GJ. Thirty years experience with heart valve surgery: isolated aortic valve replacement. Aust N Z J Surg 1996;66: 799-805.
12. He GW, Grunkemeier GL, Gately HL, Furnary AP, Starr A. Up to thirty-year survival after aortic valve replacement in the small aortic root. Ann Thorac Surg 1995;59:1056-62.